Cilansetron
Top View
- Meta-Analysis: Factors Affecting Placebo Response Rate in Irritable Bowel Syndrome. Alexander Ford, Paul Moayyedi
- Meta-Analysis: the Treatment of Irritable Bowel Syndrome
- Prokinetics in the Management of Functional Gastrointestinal Disorders
- Long-Term Efficacy and Safety of Ramosetron in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
- Lubiprostone: Evaluation of the Newest Medication for the Treatment of Adult Women with Constipation-Predominant Irritable Bowel Syndrome
- Drug Treatment of Irritable Bowel Syndrome: Different Approaches for Different Subtypes
- Neuronal 5-HT Receptors and SERT
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Brain-Gut Interactions in IBS
- Efficacy and Safety of 5-Hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: a Systematic Review and Meta- Analysis of Randomized Controlled Trials
- Randomized, Double Blinded, Placebo Controlled Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients with Bile Acid Malabsorption
- Tepzz¥ 4¥5 4A T
- (12) United States Patent (10) Patent No.: US 9.248,185 B2 Rubin Et Al
- Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders Meagan M
- How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
- Customs Tariff - Schedule Xxi - 1
- IBS-Monograph-2018.Pdf
- Pharmacology of Serotonin: What a Clinician Should Know